Skip to main content
. Author manuscript; available in PMC: 2010 Sep 10.
Published in final edited form as: Int J Cancer. 2008 May 1;122(9):2017–2022. doi: 10.1002/ijc.23340

TABLE VI.

UPTAKE OF AT LEAST ONE CANCER PREVENTION OPTION (PROPHYLACTIC MASTECTOMY, PROPHYLACTIC OOPHORECTOMY OR TAMOXIFEN) IN WOMEN WITHOUT BREAST CANCER

Austria (N = 25) Canada (N = 393) France (N = 4) Israel (N = 95) Italy (N = 20) Holland (N = 55) Norway (N = 135) Poland (N = 339) USA (N = 317)
At least one cancer prevention option 10 (40.0%) 232 (59.0%) 3 (75.0%) 55 (57.9%) 8 (40.0%) 31 (56.4%) 92 (68.2%) 89 (26.3%) 229 (72.2%)